Strs Ohio Reduces Stake in National Health Investors, Inc. (NYSE:NHI)

Strs Ohio reduced its stake in National Health Investors, Inc. (NYSE:NHI) by 2.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,500 shares of the real estate investment trust’s stock after selling 200 shares during the quarter. Strs Ohio’s holdings in National Health Investors were worth $474,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in National Health Investors by 5.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,944 shares of the real estate investment trust’s stock valued at $1,127,000 after buying an additional 1,190 shares during the period. International Assets Investment Management LLC increased its holdings in National Health Investors by 3,690.7% in the 4th quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust’s stock valued at $1,588,000 after purchasing an additional 27,680 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in National Health Investors by 4.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust’s stock valued at $10,568,000 after purchasing an additional 8,316 shares during the period. Raymond James Financial Services Advisors Inc. lifted its stake in National Health Investors by 14.4% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust’s stock worth $1,730,000 after purchasing an additional 3,907 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its stake in National Health Investors by 36.2% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,743 shares of the real estate investment trust’s stock worth $757,000 after purchasing an additional 3,916 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Up 0.4 %

Shares of NYSE NHI opened at $62.89 on Friday. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of 20.09 and a beta of 0.95. The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27. The business has a 50-day moving average of $59.75 and a two-hundred day moving average of $55.73. National Health Investors, Inc. has a 1 year low of $47.54 and a 1 year high of $63.37.

National Health Investors Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 5.72%. The ex-dividend date of this dividend is Wednesday, March 27th. National Health Investors’s dividend payout ratio (DPR) is 115.02%.

Insiders Place Their Bets

In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was bought at an average cost of $58.69 per share, with a total value of $586,900.00. Following the acquisition, the director now directly owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 7.26% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. BMO Capital Markets raised National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective for the company in a research note on Tuesday, March 12th. Wedbush lifted their price objective on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research note on Monday, March 18th. Truist Financial lifted their price objective on National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research note on Thursday, April 4th. Finally, Wells Fargo & Company raised National Health Investors from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $55.00 to $63.00 in a research note on Monday, February 26th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $60.50.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.